Selected publications
For complete list of publications:
https://scholar.google.ca/citations?hl=en&user=VYlzvg8AAAAJ&view_op=list_works&sortby=title
Nowak V, Agaimy A, Kristiansen G, Gütgemann I. Histopathology (in print). 2019. Increased IgG4 positive plasma cells in nodular-sclerosing Hodgkin lymphoma: A diagnostic pitfall.
Pelusi N, Kosanke M, Riedt T, Rösseler C, Seré K, Li J, Gütgemann I, Zenke M, Janzen V, Schorle H. Sci Rep. 2017 Jan 27;7:41427. The spleen microenvironment influences disease transformation in a mouse model of KITD816V-dependent myeloproliferative neoplasm.
Li J, Riedt T, Goossens S, Carrillo García C, Szczepanski S, Brandes M, Pieters T, Dobrosch L, Gütgemann I, Farla N, Radaelli E, Hulpiau P, Mallela N, Fröhlich H, La Starza R, Matteucci C, Chen T, Brossart P, Mecucci C, Huylebroeck D, Haigh JJ, Janzen V. Blood. 2017 Jan 26;129(4):460-472. The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW. Science. 2016 Apr 8;352(6282):227-31. MYC regulates the antitumor immune response through CD47 and PD-L1.
Niebel D, Kirfel J, Janzen V, Höller T, Majores M, Gütgemann I. Blood. 2014 Jul 3;124(1):151-2. Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms.
Morales-Kastresana A, Sanmamed MF, Rodriguez I, Palazon A, Martinez-Forero I, Labiano S, Hervas-Stubbs S, Sangro B, Ochoa C, Rouzaut A, Azpilikueta A, Bolaños E, Jure-Kunkel M, Melero I, Gütgemann I. Clin Cancer Res. 2013 Oct 28. Combined Immunostimulatory Monoclonal antibodies extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model.
Gütgemann I, Heimpel H, Nebe CT. Laboratoriumsmedizin 2013. Sept 37(5): 227ff Significance of tear drop cells in peripheral blood smears.
Peng WM, Maintz L, Allam JP, Raap U, Gütgemann I, Kirfel J, Wardelmann E, Perner S, Zhao W, Fimmers R, Walgenbach K, Oldenburg J, Schwartz LB, Novak N. Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis. Blood. 2013 Sep 5;122(10):1779-88.
Khristi J, Mey U, Kirfel J, Schmidt-Wolf IG, Gütgemann I. Sequential Hodgkin's and non- Hodgkin's lymphoma in non-immunocompromised patients. Ann Hematol. 2013 Nov;92(11):1565-7.
Ney JT, Schmidt T, Kurts C, Zhou Q, Eckert D, Felsher DW, Schorle H, Knolle P, Tüting T, Barchet W, Büttner R, Limmer A, Gütgemann I. Autochthonous liver tumors induce T-cell tolerance accociated with T cell receptor down-modulation. Hepatology 2009 Feb;49(2):471-81. Erratum in: Hepatology. 2009, 49(3):1058.
Gutgemann I, Fahrer AM, Altman JD, Davis MM, Chien Y. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998 8(6): 667-673.